Prodeon EXPANDER-2: A Multi-Center, Randomized, Blinded, Controlled Study to Evaluate the Safety and Efficacy of the Urocross(TM) Expander System and Retrieval Sheath
Study Product: Urocross Expander System vs Sham (2:1) with crossover 3M for BPH
Estimated Study Completion Date: January 2027
ClinicalTrials.gov Identifier: NCT05400980
Iterum uUTI: A Prospective, Phase 3, Randomized, Multi-center, Double-blind Study of the Efficacy, Tolerability, and Safety of Oral Sulopenem Etzadroxil/Probenecid Versus Oral Amoxicillin/Clavulanate for Treatment of Uncomplicated Urinary Tract Infections (uUTI) in Adult Women
Study Product: oral sulopenem etzadroxil/probenecid vs amoxicillin/clavulanate for uUTI in adult women
Estimated Study Completion Date: March 31, 2024
ClinicalTrials.gov Identifier: NCT05584657
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date. Please remember to talk to your healthcare providers first before making decisions about your plan of care.
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study. To learn more about our trials, call Jennifer at (843) 449-1010 ext. 316 or email us by filling out the form below.